These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30387014)

  • 1. Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer.
    Zajkowska M; Lubowicka E; Fiedorowicz W; Szmitkowski M; Jamiołkowski J; Ławicki S
    Pathol Oncol Res; 2019 Oct; 25(4):1477-1486. PubMed ID: 30387014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of VEGF-A, VEGF B, and VEGFR-1 and applicability of these parameters as tumor markers in diagnosis of breast cancer.
    Zajkowska M; Lubowicka E; Malinowski P; Szmitkowski M; Ławicki S
    Acta Biochim Pol; 2018 Dec; 65(4):621-628. PubMed ID: 30543720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Power of Vascular Endothelial Growth Factor and Macrophage Colony-Stimulating Factor in Breast Cancer Patients Based on ROC Analysis.
    Zajkowska M; Głażewska EK; Będkowska GE; Chorąży P; Szmitkowski M; Ławicki S
    Mediators Inflamm; 2016; 2016():5962946. PubMed ID: 27445439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic power of VEGF, MMP-9 and TIMP-1 in patients with breast cancer. A multivariate statistical analysis with ROC curve.
    Zajkowska M; Gacuta E; Kozłowska S; Lubowicka E; Głażewska EK; Chrostek L; Szmitkowski M; Pawłowski P; Zbucka-Krętowska M; Ławicki S
    Adv Med Sci; 2019 Mar; 64(1):1-8. PubMed ID: 30227310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.
    Al-Moundhri MS; Al-Shukaili A; Al-Nabhani M; Al-Bahrani B; Burney IA; Rizivi A; Ganguly SS
    World J Gastroenterol; 2008 Jun; 14(24):3879-83. PubMed ID: 18609713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and diagnostic utility of VEGF, MMP-2 and TIMP-2 in the diagnostics of breast cancer patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Biomarkers; 2017 Mar; 22(2):157-164. PubMed ID: 27775427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?
    Zajkowska M; Gacuta E; Lubowicka E; Szmitkowski M; Ławicki S
    Acta Biochim Pol; 2020 Mar; 67(1):25-29. PubMed ID: 32160452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factors a, C and d in human breast tumors.
    Gisterek I; Matkowski R; Lacko A; Sedlaczek P; Szewczyk K; Biecek P; Halon A; Staszek U; Szelachowska J; Pudelko M; Bebenek M; Harlozinska-Szmyrka A; Kornafel J
    Pathol Oncol Res; 2010 Sep; 16(3):337-44. PubMed ID: 19821158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Levels and Diagnostic Utility of M-CSF, MMP-2 and its Inhibitor TIMP-2 in the Diagnostics of Breast Cancer Patients.
    Ławicki S; Zajkowska M; Głażewska EK; Będkowska GE; Szmitkowski M
    Clin Lab; 2016 Sep; 62(9):1661-1669. PubMed ID: 28164586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Analysis.
    Zajkowska M; Zbucka-Krętowska M; Sidorkiewicz I; Lubowicka E; Będkowska GE; Gacuta E; Szmitkowski M; Ławicki S
    Cancer Control; 2018; 25(1):1073274818789357. PubMed ID: 30037277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
    Sawada M; Oishi T; Komatsu H; Sato S; Chikumi J; Nonaka M; Kudoh A; Osaku D; Harada T
    Int J Clin Oncol; 2019 Dec; 24(12):1612-1619. PubMed ID: 31236742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
    Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
    Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
    Chen C; Chen Q; Dong Y; Liu X
    Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF, M-CSF and CA 15-3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve.
    Ławicki S; Będkowska GE; Szmitkowski M
    Growth Factors; 2013 Jun; 31(3):98-105. PubMed ID: 23688065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Chemokine CCL2 and Its Receptor CCR2 Concentrations as Diagnostic Biomarkers for Breast Cancer Patients.
    Lubowicka E; Przylipiak A; Zajkowska M; Piskór BM; Malinowski P; Fiedorowicz W; Ławicki S
    Biomed Res Int; 2018; 2018():2124390. PubMed ID: 30151375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia.
    Singh A; Gautam KA; Dalela D; Sankhwar S; Natu S; Sankhwar P; Srivastava A
    Asian Pac J Cancer Prev; 2013; 14(3):2053-8. PubMed ID: 23679318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
    El-Attar NI; Gaefar HA
    Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma levels of tissue factor as a valuable diagnostic biomarker with relevant efficacy for prediction of breast cancer morbidity.
    Zarychta E; Rhone P; Bielawski K; Rosc D; Szot K; Zdunska M; Ruszkowska-Ciastek B
    J Physiol Pharmacol; 2018 Dec; 69(6):. PubMed ID: 30802214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of VEGF-C, VEGF-D and VEGFR-3 levels combined with serum TSH in diagnosis of papillary thyroid carcinoma].
    Huang J; Li Y; Xue G; Zhang W; Li S; Zhang J; Wu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1814-7, 1821. PubMed ID: 25537909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical usefulness of assessing VEGF and soluble receptors sVEGFR-1 and sVEGFR-2 in women with breast cancer.
    Thielemann A; Baszczuk A; Kopczyński Z; Kopczyński P; Grodecka-Gazdecka S
    Ann Agric Environ Med; 2013; 20(2):293-7. PubMed ID: 23772579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.